Nephrolithiasis is the pathological formation or presence of solid concretions (calculi) within the renal pelvis or calyces of the kidney. It is distinguished from urolithiasis, which broadly refers to stones anywhere in the urinary tract, and ureterolithiasis, where a stone has migrated out of the kidney and into the ureter. The condition arises from the physicochemical mechanism of urinary supersaturation, where solutes like calcium, oxalate, or uric acid exceed their solubility in urine, leading to crystal nucleation, growth, and aggregation. Nephrolithiasis is strictly a pathological process, though patients may remain asymptomatic until a calculus causes urinary obstruction, mucosal irritation, or infection. The most commonly encountered clinical subtypes include calcium oxalate, calcium phosphate, uric acid, struvite, and cystine stones (all coded primarily under N20.0). It is sometimes confused with cholelithiasis, but the key difference is the anatomic location: nephrolithiasis involves stones in the kidneys, whereas cholelithiasis involves stones in the gallbladder.
Noun-forming suffix — “morbid state or condition of”
The word entered English in the 1880s as nephrolithiasis (noun), borrowed from New Latin, which synthesized the ancient Greek roots — literally “a diseased condition of kidney stones.” The root lith- (“stone”) connects nephrolithiasis to the entire lith- FAMILY: cholelithiasis (gall + stone + condition → gallstones), urolithiasis (urine + stone + condition → urinary tract stones), and lithotripsy (stone + crushing → procedure to crush stones). The combining form nephro- is highly productive in medical terminology, appearing in terms like nephritis, nephropathy, and hydronephrosis.
🔀 ALIASES / ALTERNATE TERMS
Nephrolithic(adjective form — e.g., “nephrolithic disease,” “nephrolithic burden”)
Kidney stones(lay term; common in both general and clinical settings)
Renal calculi(clinical synonym; highly prevalent in radiology, urology, and nephrology)
Microlithiasis(partial/lesser form — presence of tiny, sand-like stones or gravel in the kidneys)
Staghorn calculus(systemic or syndromic form — large, branching stone filling the renal pelvis and calyces, typically composed of struvite and associated with chronic UTI)
Calcium oxalate stones(etiologic subtype 1 — the most common stone type, often driven by hypercalciuria, hyperoxaluria, or low fluid intake)
Uric acid stones(etiologic subtype 2 — radiolucent stones driven by persistently acidic urine and purine metabolism disorders)
Calyceal stones(anatomic subtype 1 — stones located specifically in the renal calyces; N20.0)
Renal pelvic stones(anatomic subtype 2 — stones located in the central collecting cavity of the kidney; N20.0)
🔗 RELATED TERMS
Stone-free state — the functional opposite of nephrolithiasis; achieved post-intervention or post-passage, indicating complete clearance of the calculus burden.
Nephrocalcinosis — shares the nephro- root; the deposition of calcium salts in the renal parenchyma (tissue) itself, rather than as free-floating stones in the collecting system.
Ureterolithiasis — closely related clinical entity; the presence of a stone in the ureter, usually a migrating kidney stone [N20.1].
Hydronephrosis — complex condition that overlaps with this term; dilation of the renal pelvis and calyces, frequently caused by the obstruction of urine flow by a migrating kidney stone.
Urinary supersaturation — the physicochemical mechanism where urinary solutes exceed their solubility limits, triggering the precipitation of crystals.
Lithogenic — adjective describing metabolic, dietary, or environmental inputs that promote stone formation; e.g., a “lithogenic diet” high in sodium and animal protein.
Crystallization — the molecular process underlying the initial formation and growth of calculi.
Hyperparathyroidism — an endocrine disease whose manifestations frequently include hypercalcemia and subsequent secondary nephrolithiasis (E21.0).
Gout — a clinical entity characterized by hyperuricemia, strongly associated with uric acid nephrolithiasis (M10.9).
Computed Tomography (CT) without contrast — the gold-standard primary diagnostic imaging procedure for evaluating nephrolithiasis.
Cystourethroscopy, with ureteroscopy and/or pyeloscopy; with lithotripsy including insertion of indwelling ureteral stent (eg, Gibbons or double-J type)
Percutaneous nephrostolithotomy or pyelostolithotomy, with or without dilation, endoscopy, lithotripsy, stenting, or basket extraction; over 2 cm
74176
Computed tomography, abdomen and pelvis; without contrast material (primary diagnostic scan)
74400
Urography (pyelography), intravenous, with or without KUB, with or without tomography
⚠️ Coding Note: For inpatient profee coding, it is critical to note that the primary ICD-10-CM code for a kidney stone (N20.0) does not require lateralization (left vs. right). However, the corresponding CPT surgical codes (e.g., 50590, 52356) strictly require laterality modifiers (-RT, -LT, or -50 for bilateral) for reimbursement. Correct sequencing is vital for overlapping conditions: if a patient is admitted with sepsis due to an obstructing stone, sequence the systemic sepsis code first, followed by the localized UTI, and then the stone. A common undercoding alert occurs when providers only document “flank pain” or “renal colic”; querying the provider to confirm “flank pain due to kidney stone” is necessary to code the definitive diagnosis rather than a symptom code. Finally, ensure stone size is explicitly documented in the operative report, as percutaneous removal codes (50080 vs 50081) are entirely dependent on whether the stone burden is up to 2 cm or over 2 cm.
Crystal's Coder Hub